With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
SNPS — frequently asked questions
Is Synopsys Inc. overvalued?
In our latest published analysis dated 2026-05-10, SNPS looks meaningfully overvalued. The price recorded at analysis is USD 516 versus our fair value of USD 294; the high endpoint is presented separately as potential value of USD 386. That implies roughly 43.1% downside to fair value at that date.
Our latest published report, analyzed 2026-05-10, gives SNPS a fair value of USD 294 and a potential value of USD 386. The conclusion is triangulated across multiple valuation models and weighted by reliability for Synopsys Inc.'s archetype; it is a dated research output, not a live price.
Should I buy SNPS now?
Our latest published rating for SNPS, analyzed 2026-05-10, is Sell. Synopsys Inc. looks meaningfully overvalued at the analysis-date price of USD 516 versus fair value of USD 294; potential value is USD 386. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for SNPS?
The dedicated bear-case section in our report analyzed 2026-05-10 documents Synopsys Inc.'s material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is SNPS's rating?
Our latest published rating for SNPS, analyzed 2026-05-10, is Sell, with a published moat assessment of 9/10 (Wide). It reflects our fair value of USD 294, the potential value of USD 386, and the price recorded at analysis (USD 516).
Bull: AI significantly accelerates chip development cycles, increasing seat licenses and compute usage.
Main risk
M&A Integration Failure: The recent transformative acquisition faces severe cultural and technical friction, causing delayed synergies and margin compression.
Synopsys operates as a dominant player in the consolidated EDA oligopoly. Secular tailwinds from increasing semiconductor complexity ensure mission-critical reliance on its software. However, a massive recent acquisition significantly boosts scale but temporarily pressures balance sheet health and operating margins.
Synopsys operates as a dominant player in the consolidated EDA oligopoly. Secular tailwinds from increasing semiconductor complexity ensure mission-critical reliance on its software. However, a massive recent acquisition significantly boosts scale but temporarily pressures balance sheet health and operating margins.
Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries. It operates in two segments, Design Automation and Design IP. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; FPGA design products that are programmed to perform specific functions; synopsys technology computer-aided design (TCAD), mask synthesis, and manufacturing analytic solutions; and AI-driven EDA solutions. It also provides pre-verified and silicon-proven IP solutions, logic libraries and embedded memories, processor and security solutions, IP Offerings for the automotive market, SOC infrastructure IP, data path and building block IP, and mathematical and floating-point components. Synopsys, Inc. has a strategic collaboration with Arm Holdings plc for development of AGI CPU that provides solutions across its full-stack design portfolio including EDA, interface IP, and hardware-assisted verification (HAV). The company was incorporated in 1986 and is headquartered in Sunnyvale, California.
Under a recessionary stress test, top-line growth stalls to low single digits while the heavy fixed-cost base and massive $13.4B debt load decimate free cash flow. This combination leaves management unable to deleverage organically, forcing highly dilutive capital raises.
AI significantly accelerates chip development cycles, increasing seat licenses and compute usage. Massive synergies from recent acquisitions are realized, expanding beyond 30% and rapidly deleveraging the balance sheet.
§7 Earnings decision tree
Beat
Hold or add selectively
Trigger: Upside surprise
If margins expand >25%, the stock may catch a bid. If revenue synergies stall, severe multiple contraction ensues.
In-line
Hold
Trigger: In-line results
If margins expand >25%, the stock may catch a bid. If revenue synergies stall, severe multiple contraction ensues.
Miss
Reassess
Trigger: Downside surprise
If margins expand >25%, the stock may catch a bid. If revenue synergies stall, severe multiple contraction ensues.
Heavy consolidation phase, marked by SNPS taking on significant leverage to acquire scale.
Bull cycle
Accelerating AI-driven chip designs and reshoring of fabs increase EDA software demand.
Bear cycle
Overcapacity in chip manufacturing leads to slashed R&D budgets.
Positioning
Heavy consolidation phase, marked by SNPS taking on significant leverage to acquire scale.
§11 Position management
Sizing
Zero weight currently advised given the -43% downside to fair value.
Risk
Sell existing allocations into the current market optimism that prices in flawless post-M&A execution.
Entry tranches
Level
Action
Why
Current / pullbacks
Await significant multiple contraction or definitive proof of margin expansion and debt paydown closer to the $250 level.
Await significant multiple contraction or definitive proof of margin expansion and debt paydown closer to the $250 level.
§12 Investor perspectives
Bull view
Buy
Upside case depends on the report valuation range and named growth catalysts.
Base view
Sell
Intrinsic models heavily penalize the new capital structure, whereas internal valuation cross-checks completely ignore the $13.4B debt load and fading ROIC.
§14 Final recommendation
Action
Sell
Sell. The current $516 price implies flawless execution of the recent mega-acquisition, ignoring the severely altered balance sheet and noisy trailing financials.
Reassess the thesis against the named valuation, risk, and quarterly checkpoint evidence in this report.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
A cyclical downturn in global semiconductor R&D slows organic growth. The heavy debt burden from recent M&A restricts financial flexibility, and integration hurdles cause prolonged margin compression and sluggish earnings growth.
A cyclical downturn in global semiconductor R&D slows organic growth. The heavy debt burden from recent M&A restricts financial flexibility, and integration hurdles cause prolonged margin compression and sluggish earnings growth.
Ways this thesis can break
M&A Integration Failure
Medium
The recent transformative acquisition faces severe cultural and technical friction, causing delayed synergies and margin compression.
FV impact
-30%
Prolonged Semiconductor Cyclical Downturn
Low
A severe pullback in global fab and R&D spending directly hits EDA tool renewals and seat expansions.
FV impact
-25%
Debt Servicing Crisis
Low
The massive $13.4B debt load restricts operational flexibility amid rising interest rates, forcing dilutive equity raises or asset firesales.
FV impact
-40%
Early-warning signals to monitor
The five developments that would weaken our investment case.
Subdued cash flow conversion impairs organic debt repayment capacity following major acquisitions. Failure to convert operating income into free cash flow increases refinancing vulnerability, elevates interest expense burdens, and limits capital deployment flexibility.
A sharp deceleration in top-line growth indicates that semiconductor design budgets and license renewals are contracting globally. Lower revenue growth limits operating leverage across extensive software development teams and pressures elevated valuation multiples.
Depressed capital returns confirm that massive acquisition outlays and goodwill are diluting corporate capital efficiency. Inability to generate returns above the cost of capital destroys economic value and impairs long-term equity compounding.
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and at , then adjust for signed per current share.
AI significantly accelerates chip development cycles, increasing seat licenses and compute usage. Massive synergies from recent acquisitions are realized, expanding operating margins beyond 30% and rapidly deleveraging the balance sheet.
M&A integration proceeds with normal friction. Margins slowly recover to the 25% historical baseline, and organic growth normalizes at 8-10%, though the debt burden caps significant multiple expansion.
M&A integration proceeds with normal friction. Margins slowly recover to the 25% historical baseline, and organic growth normalizes at 8-10%, though the debt burden caps significant multiple expansion.
If margins expand >25%, the stock may catch a bid. If revenue synergies stall, severe multiple contraction ensues.
Warning level: < 8.0% over two consecutive quarters. A sharp deceleration in top-line growth indicates that semiconductor design budgets and license renewals are contracting globally. Lower revenue growth limits operating leverage across extensive software development teams and pressures elevated valuation multiples.
Warning level: < 2.0% over trailing twelve months. Depressed capital returns confirm that massive acquisition outlays and goodwill are diluting corporate capital efficiency. Inability to generate returns above the cost of capital destroys economic value and impairs long-term equity compounding.